ArticleOncoimmunology2025

Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor models.

Kimberly Pojar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.